D. E. Shaw & Co., Inc. Procaps Group, S.A. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.33 - $9.4 $1.2 Million - $1.54 Million	164,288 Added 541.78%	194,612 $1.81 Million
Q1 2022 May 16, 2022	SELL	$7.97 - $9.85 $1.16 Million - $1.43 Million	-145,379 Reduced 82.74%	30,324 $258,000
Q4 2021 Feb 14, 2022	SELL	$8.85 - $10.42 $173,460 - $204,232	-19,600 Reduced 10.04%	175,703 $1.71 Million
Q3 2021 Nov 15, 2021	BUY	$9.25 - $10.76 $1.81 Million - $2.1 Million	195,303 New	195,303 $1.99 Million

104K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $282M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.